Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 5, 2012, Pages 1981-1987

  Samuelian, Jason M ^a   Callister, Matthew D ^a   Ashman, Jonathan B ^a   Young Fadok, Tonia M ^a   Borad, Mitesh J ^a   Gunderson, Leonard L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Intensity modulated radiation therapy; Preoperative radiotherapy; Rectal cancer

Indexed keywords

ACUTE TOXICITY; ADVERSE EVENTS; ARIZONA; BONE MARROW; BOWEL TOXICITY; CLINICAL OUTCOME; COMMON TERMINOLOGY CRITERIA; CONCURRENT CHEMOTHERAPY; GASTROINTESTINAL TOXICITIES; GI TRACT; INTENSITY MODULATED RADIATION THERAPY; INTENSITY-MODULATED RADIOTHERAPY; PATHOLOGIC COMPLETE RESPONSE; PELVIC RADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; RECTAL CANCER; SIDE EFFECT; SMALL BOWEL; TREATMENT GROUP; TUMOR RESPONSE;

CHEMOTHERAPY; DISEASES; PATIENT MONITORING; PHYSICAL THERAPY; RADIOTHERAPY; TOXICITY; TUMORS;

CHEMORADIOTHERAPY;

CAPECITABINE; FLUOROURACIL;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; DEHYDRATION; DIARRHEA; ENTERITIS; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAUSEA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROCTITIS; RADIATION SICKNESS; RECTUM CANCER; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; DIARRHEA; ENTERITIS; FEMALE; HUMANS; INTESTINES; MALE; MIDDLE AGED; PREOPERATIVE PERIOD; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; URINARY BLADDER;

EID: 84858705662     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.01.051     Document Type: Article

References (40)

1. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000;92:388-396. (Pubitemid 30154820)
2. Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009;27:5124-5130.
3. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
4. Smalley SR, Benedetti JK, Williamson SK, et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 2006;24:3542-3547. (Pubitemid 46630524)
5. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114-1123. (Pubitemid 44394918)
6. Mak AC, Rich TA, Schultheiss TE, et al. Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys 1994;28:597-603. (Pubitemid 24072743)
7. Robertson JM, Lockman D, Yan D, et al. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2008;70:413-418.
8. Baglan KL, Frazier RC, Yan D, et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2002;52:176-183. (Pubitemid 34041570)
9. Gunnlaugsson A, Kjellen E, Nilsson P, et al. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol 2007;46:937-944. (Pubitemid 47537183)
10. Salama JK, Mell LK, Schomas DA, et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience. J Clin Oncol 2007;25:4581-4586. (Pubitemid 350035316)
11. Mundt AJ, Lujan AE, Rotmensch J, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;52:1330-1337. (Pubitemid 34296492)
12. Ashman JB, Zelefsky MJ, Hunt MS, et al. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:765-771. (Pubitemid 41400064)
13. Callister M, Ezzell GA, Gunderson LL. IMRT reduces the dose to small bowel and other pelvic in the preoperative treatment of rectal cancer. Int J Radiat Oncol Biol Phys 2006;66:S290.
14. Engels B, De Ridder M, Tournel K, et al. Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: Impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys 2009;74:1476-1480.
15. Guerrero Urbano MT, Henrys AJ, Adams EJ, et al. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 2006;65:907-916. (Pubitemid 43795830)
16. Duthoy W, De Gersem W, Vergote K, et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys 2004;60:794-806. (Pubitemid 39311759)
17. Nuyttens JJ, Robertson JM, Yan D, et al. The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer. Cancer Radiother 2004;8:297-304. (Pubitemid 39550787)
18. Arbea L, Ramos LI, Martinez-Monge R, et al. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): Dosimetric comparison and clinical implications. Radiat Oncol 2010;5:17.
19. Aristu JJ, Arbea L, Rodriguez J, et al. Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2008;71:748-755.
20. De Ridder M, Tournel K, Van Nieuwenhove Y, et al. Phase II study of preoperative helical tomotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2008;70:728-734. (Pubitemid 351199707)
21. Ballonoff A, Kavanagh B, McCarter M, et al. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: A phase II trial. Am J Clin Oncol 2008;31:264-270.
22. Tho LM, Glegg M, Paterson J, et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 2006;66:505-513. (Pubitemid 44332729)
23. Pinkawa M, Gagel B, Demirel C, et al. Dose-volume histogram evaluation of prone and supine patient position in external beam radiotherapy for cervical and endometrial cancer. Radiother Oncol 2003;69:99-105. (Pubitemid 37346193)
24. Kim TH, Chie EK, Kim DY, et al. Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients. Int J Radiat Oncol Biol Phys 2005;62:769-775.
25. Stromberger C, Kom Y, Kawgan-Kagan M, et al. Intensity-modulated radiotherapy in patients with cervical cancer: An intra-individual comparison of prone and supine positioning. Radiat Oncol 2010;5:63.
26. Kim JY, Kim DY, Kim TH, et al. Intensity-modulated radiotherapy with a belly board for rectal cancer. Int J Colorectal Dis 2007;22:373-379. (Pubitemid 46336240)
27. Beriwal S, Jain SK, Heron DE, et al. Dosimetric and toxicity comparison between prone and supine position IMRT for endometrial cancer. Int J Radiat Oncol Biol Phys 2007;67:485-489. (Pubitemid 46108311)
28. Mell LK, Schomas DA, Salama JK, et al. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:1431-1437. (Pubitemid 351417769)
29. Brixey CJ, Roeske JC, Lujan AE, et al. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;54:1388-1396. (Pubitemid 35380039)
30. Myerson R, Drzymala R. Technical aspects of image-based treatment planning of rectal carcinoma. Semin Radiat Oncol 2003;13:433-440. (Pubitemid 37377605)
31. Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results - EORTC 22921. J Clin Oncol 2005;23:5620-5627.
32. Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006;24:4620-4625. (Pubitemid 46630960)
33. Gallagher MJ, Brereton HD, Rostock RA, et al. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 1986;12:1565-1573. (Pubitemid 17175240)
34. Letschert JG, Lebesque JV, Aleman BM, et al. The volume effect in radiation-related late small bowel complications: Results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiother Oncol 1994;32:116-123. (Pubitemid 24270732)
35. Tournel K, De Ridder M, Engels B, et al. Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography. Int J Radiat Oncol Biol Phys 2008;71:934-939. (Pubitemid 351749525)
36. Robertson JM, Campbell JP, Yan D. Generic planning target margin for rectal cancer treatment setup variation. Int J Radiat Oncol Biol Phys 2009;74:1470-1475.
37. Gerard JP, Chapet O, Nemoz C, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial. J Clin Oncol 2003;21:1119-1124. (Pubitemid 46594142)
38. Roels S, Duthoy W, Haustermans K, et al. Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 2006;65:1129-1142.
39. Nuyttens JJ, Robertson JM, Yan D, et al. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys 2002;53:497-503. (Pubitemid 34522116)
40. Ahamad A, D'Souza W, Salehpour M, et al. Intensity-modulated radiation therapy after hysterectomy: Comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys 2005;62:1117-1124. (Pubitemid 40884426)